Clinical Study of Injectable Ceramics Bone Graft Substitute Containing rhBMP-2

BioAlpha Inc.88 enrolled

Overview

This is a prospective, outcomes assessor-blinded, randomized study to evaluate the efficacy and safety of "Inject BMP(Injectable Ceramics Bone Graft Substitute Containing rhBMP-2)" for socket preservation after extraction of a single-rooted tooth, compared to ExcelOS-inject(Injectable Ceramics Bone Graft Substitute).

Inject BMP is Injectable Ceramics Bone Graft Substitute(ExcelOS-inject) containing rhBMP-2. Recombinant human Bone morphogenetic protein 2 (rhBMP-2) stimulates the production of bone.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Enrollment

Conditions

Alveolar Bone Preservation Bone Graft

Interventions

Inject BMPDEVICE

Injection of ExcelOS-inject(beta-TCP) containing rhBMP-2.

ExcelOS-injectDEVICE

Injection of ExcelOS-inject(beta-TCP) without rhBMP-2.

Eligibility

Sex: ALLMin age: 19 YearsMax age: 80 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Persons without periodontal disease Exclusion Criteria: * Women who are pregnant or plan to be pregnant within study period

Outcomes

Primary Outcomes

compared the changed height and standard height by computed tomography.

Time frame: at 12 weeks after surgery

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.